(Q48297126)

10 February 2018

title

Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. (English)

1 reference

10 February 2018

0 references

1 reference

W A Banks

1

1 reference

10 February 2018

A J Kastin

2

1 reference

10 February 2018

A J Fischman

3

1 reference

10 February 2018

D H Coy

4

1 reference

10 February 2018

S L Strauss

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 October 1986

1 reference

10 February 2018

American Journal of Physiology

published in

1 reference

10 February 2018

volume

251

1 reference

10 February 2018

issue

4 Pt 1

1 reference

10 February 2018

page(s)

E477-82

1 reference

10 February 2018

Permeability of the blood-brain barrier to neuropeptides: the case for penetration.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Aging and the blood-brain barrier: changes in the carrier-mediated transport of peptides in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Aluminum alters the permeability of the blood-brain barrier to some non-peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

The aluminum-induced increase in blood-brain barrier permeability to delta-sleep-inducing peptide occurs throughout the brain and is independent of phosphorus and acetylcholinesterase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

A brain-to-blood carrier-mediated transport system for small, N-Tyrosinated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: some correlations with protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Sodium transport from blood to brain: inhibition by furosemide and amiloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Factors affecting the distribution of iodide and bromide in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Blood-brain barrier restriction of peptides and the low uptake of enkephalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Active transport of 131-I across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Insulin increases glucose transfer across the blood-brain barrier in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

The accumulation of (3H) enkephalinamide (2-D-alanine-5-methioninamide) in rat brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Differential penetration of DSIP peptides into rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Permeability of blood-brain barrier to DSIP peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Distribution of 3H-alpha-MSH in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

CNS effects of peripherally administered brain peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Ventricular, paraventricular and circumventricular structures involved in peptide-induced satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Interactions between the antiopiate Tyr-MIF-1 and the mu opiate morphiceptin at their respective binding sites in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1986.251.4.E477

10.1152/AJPENDO.1986.251.4.E477

21 January 2018

Identifiers

DOI

0 references

PubMed ID

2876644

1 reference

10 February 2018